End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.395 USD | -14.13% | -43.57% | -97.38% |
May. 14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 10 | Liquidation Plan and Disclosure Statement Filed by Acorda Therapeutics, Inc. | CI |
Financials (USD)
Sales 2022 | 119M | Sales 2023 | 118M | Capitalization | 18.74M |
---|---|---|---|---|---|
Net income 2022 | -65M | Net income 2023 | -253M | EV / Sales 2022 | 1.3 x |
Net Debt 2022 | 135M | Net Debt 2023 | 161M | EV / Sales 2023 | 1.53 x |
P/E ratio 2022 |
-0.23
x | P/E ratio 2023 |
-0.07
x | Employees | 102 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.33% |
Latest transcript on Acorda Therapeutics, Inc.
1 day | -14.13% | ||
1 week | -43.57% | ||
1 month | -53.41% | ||
3 months | -97.22% | ||
6 months | -96.17% | ||
Current year | -97.38% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.395 | -14.13% | 51,428 |
24-05-30 | 0.46 | -18.58% | 39,338 |
24-05-29 | 0.565 | -2.59% | 8,170 |
24-05-28 | 0.58 | -17.14% | 54,960 |
24-05-24 | 0.7 | -6.67% | 41,081 |
End-of-day quote OTC Markets, May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-97.38% | 491K | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ACOR.Q Stock